These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 25114109)

  • 1. LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague.
    Sun W; Sanapala S; Henderson JC; Sam S; Olinzock J; Trent MS; Curtiss R
    Infect Immun; 2014 Oct; 82(10):4390-404. PubMed ID: 25114109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Recombinant Attenuated
    Singh AK; Curtiss R; Sun W
    Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.
    Arnaboldi PM; Sambir M; D'Arco C; Peters LA; Seegers JF; Mayer L; McCormick AA; Dattwyler RJ
    Vaccine; 2016 Nov; 34(47):5768-5776. PubMed ID: 27745954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection Induced by Oral Vaccination with a Recombinant
    Majumder S; Olson RM; Singh A; Wang X; Li P; Kittana H; Anderson PE; Anderson DM; Sun W
    Infect Immun; 2022 Aug; 90(8):e0016522. PubMed ID: 35900096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plague.
    Derbise A; Cerdà Marín A; Ave P; Blisnick T; Huerre M; Carniel E; Demeure CE
    PLoS Negl Trop Dis; 2012; 6(2):e1528. PubMed ID: 22348169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral vaccination with live attenuated Yersinia pseudotuberculosis strains delivering a FliC180-LcrV fusion antigen confers protection against pulmonary Y. Pestis infection.
    Singh AK; Wang X; Sun W
    Vaccine; 2020 May; 38(21):3720-3728. PubMed ID: 32278523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.
    Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE
    PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A bivalent typhoid live vector vaccine expressing both chromosome- and plasmid-encoded Yersinia pestis antigens fully protects against murine lethal pulmonary plague infection.
    Galen JE; Wang JY; Carrasco JA; Lloyd SA; Mellado-Sanchez G; Diaz-McNair J; Franco O; Buskirk AD; Nataro JP; Pasetti MF
    Infect Immun; 2015 Jan; 83(1):161-72. PubMed ID: 25332120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague.
    Branger CG; Fetherston JD; Perry RD; Curtiss R
    Adv Exp Med Biol; 2007; 603():387-99. PubMed ID: 17966435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yersinia pestis with regulated delayed attenuation as a vaccine candidate to induce protective immunity against plague.
    Sun W; Roland KL; Kuang X; Branger CG; Curtiss R
    Infect Immun; 2010 Mar; 78(3):1304-13. PubMed ID: 20086087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challenge.
    Branger CG; Sun W; Torres-Escobar A; Perry R; Roland KL; Fetherston J; Curtiss R
    Vaccine; 2010 Dec; 29(2):274-82. PubMed ID: 20979987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinatorial Viral Vector-Based and Live Attenuated Vaccines without an Adjuvant to Generate Broader Immune Responses to Effectively Combat Pneumonic Plague.
    Kilgore PB; Sha J; Hendrix EK; Motin VL; Chopra AK
    mBio; 2021 Dec; 12(6):e0322321. PubMed ID: 34872353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of
    Tong Z; Zhang X; Guo X; Wu G; Cao S; Zhang Y; Meng X; Wang T; Wang Y; Song Y; Yang R; Du Z
    mSphere; 2024 Sep; 9(9):e0033024. PubMed ID: 39158304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine Potential of a Recombinant Bivalent Fusion Protein LcrV-HSP70 Against Plague and Yersiniosis.
    Gupta A; Narayan B; Kumar S; Verma SK
    Front Immunol; 2020; 11():988. PubMed ID: 32595634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple antigens of Yersinia pestis delivered by live recombinant attenuated Salmonella vaccine strains elicit protective immunity against plague.
    Sanapala S; Rahav H; Patel H; Sun W; Curtiss R
    Vaccine; 2016 May; 34(21):2410-2416. PubMed ID: 27060051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the protective immune response to Yersinia pseudotuberculosis infection in mice vaccinated with an LcrV-secreting strain of Lactococcus lactis.
    Daniel C; Titecat M; Poiret S; Cayet D; Boutillier D; Simonet M; Sirard JC; Lemaître N; Sebbane F
    Vaccine; 2016 Nov; 34(47):5762-5767. PubMed ID: 27742220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague.
    Yamanaka H; Hoyt T; Yang X; Golden S; Bosio CM; Crist K; Becker T; Maddaloni M; Pascual DW
    Infect Immun; 2008 Oct; 76(10):4564-73. PubMed ID: 18694965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine.
    Demeure CE; Derbise A; Guillas C; Gerke C; Cauchemez S; Carniel E; Pizarro-Cerdá J
    Vaccine; 2019 Jan; 37(1):123-129. PubMed ID: 30467064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of a recombinant attenuated Yersinia pseudotuberculosis strain elicits protective immunity against plague.
    Sun W; Sanapala S; Rahav H; Curtiss R
    Vaccine; 2015 Nov; 33(48):6727-35. PubMed ID: 26514425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague.
    Lin JS; Park S; Adamovicz JJ; Hill J; Bliska JB; Cote CK; Perlin DS; Amemiya K; Smiley ST
    Vaccine; 2010 Dec; 29(2):357-62. PubMed ID: 20840834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.